Starlake Bioscience Co Inc Zhaoqing Guangdong Capital Reinvestment Ratio
Starlake Bioscience Co Inc Zhaoqing Guangdong capital reinvestment ratio. Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Capital Reinvestment Ratio of 0.52x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥1.25 Billion) in capital expenditures (CN¥652.49 Million). See Starlake Bioscience Co Inc Zhaoqing Guan free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Capital reinvestment ratio of Starlake Bioscience Co Inc Zhaoqing Guangdong from 1998 to 2025. This chart tracks Starlake Bioscience Co Inc Zhaoqing Guangdong's Capital Reinvestment Ratio across 25 annual periods. See Starlake Bioscience Co Inc Zhaoqing Guan financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Starlake Bioscience Co Inc Zhaoqing Guangdong Capital Reinvestment Ratio by Year (1998–2025)
Starlake Bioscience Co Inc Zhaoqing Guangdong capital reinvestment ratio by year from 1998 to 2025. For the full cash flow conversion analysis, see Starlake Bioscience Co Inc Zhaoqing Guan cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.58x | CN¥1.29 Billion | CN¥2.04 Billion | ▲ +492.5% |
| 2024 | 0.27x | CN¥2.40 Billion | CN¥638.50 Million | ▲ +43.6% |
| 2023 | 0.19x | CN¥2.03 Billion | CN¥375.83 Million | ▼ -31.8% |
| 2022 | 0.27x | CN¥1.66 Billion | CN¥452.34 Million | ▼ -74.4% |
| 2021 | 1.06x | CN¥192.63 Million | CN¥205.08 Million | ▼ -8.2% |
| 2020 | 1.16x | CN¥249.99 Million | CN¥289.89 Million | ▲ +57.0% |
| 2019 | 0.74x | CN¥213.17 Million | CN¥157.41 Million | ▲ +11.0% |
| 2018 | 0.67x | CN¥50.69 Million | CN¥33.71 Million | ▼ -34.4% |
| 2017 | 1.01x | CN¥40.05 Million | CN¥40.61 Million | ▲ +3.7% |
| 2016 | 0.98x | CN¥41.17 Million | CN¥40.26 Million | ▼ -97.4% |
| 2015 | 37.70x | CN¥2.75 Million | CN¥103.49 Million | ▲ +189.0% |
| 2011 | 13.05x | CN¥65.88 Million | CN¥859.52 Million | ▲ +244.3% |
| 2010 | 3.79x | CN¥104.63 Million | CN¥396.40 Million | ▲ +1816.9% |
| 2009 | 0.20x | CN¥316.73 Million | CN¥62.60 Million | ▼ -41.1% |
| 2008 | 0.34x | CN¥148.93 Million | CN¥49.97 Million | ▼ -63.1% |
| 2007 | 0.91x | CN¥82.28 Million | CN¥74.90 Million | ▼ -58.6% |
| 2006 | 2.20x | CN¥35.14 Million | CN¥77.37 Million | ▲ +47.8% |
| 2005 | 1.49x | CN¥46.83 Million | CN¥69.77 Million | ▼ -80.4% |
| 2004 | 7.60x | CN¥29.05 Million | CN¥220.76 Million | ▲ +932.9% |
| 2003 | 0.74x | CN¥149.70 Million | CN¥110.12 Million | ▲ +52.8% |
| 2002 | 0.48x | CN¥183.18 Million | CN¥88.18 Million | ▼ -62.1% |
| 2001 | 1.27x | CN¥60.82 Million | CN¥77.35 Million | ▲ +76.9% |
| 2000 | 0.72x | CN¥93.41 Million | CN¥67.16 Million | ▼ -52.1% |
| 1999 | 1.50x | CN¥52.97 Million | CN¥79.45 Million | ▼ -6.2% |
| 1998 | 1.60x | CN¥71.14 Million | CN¥113.73 Million | — |